Search research articles
Contact Us
Filters
Showing results (511-520 of 918) with videos related to
Page
of 92
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 7, 2014
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma
Paul Monk, Elaine Lam, Amir Mortazavi, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 7, 2021
Fluctuations in depression and anxiety predict dysregulated leptin among obese breast cancer survivors
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Iscience
|
June 13, 2024
Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition
Ronan C Bracken, Lindsay M Davison, Dennis P Buehler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Evaluation of <sup>18</sup>F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A
Mika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2014
Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal
Kelly P Cosgrove, Reese McKay, Irina Esterlis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 10, 2017
Kinetic evaluation and test-retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
Sjoerd J Finnema, Nabeel B Nabulsi, Joël Mercier, et al.
Psycho-Oncology
|
June 25, 2022
Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 21, 2016
Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy
Lorena P Suarez-Kelly, Amanda R Campbell, Isaac V Rampersaud, et al.
Molecular Oncology
|
February 10, 2015
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz, Mohd W Nasser, Janani Ravi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 8, 2021
Assessment of test-retest reproducibility of [<sup>18</sup>F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
Songye Li, Mika Naganawa, Richard Pracitto, et al.
Page
of 92
Search research articles
Search
Showing results (511-520 of 918) with videos related to
Sort By:
Page
of 92
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 7, 2014
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma
Paul Monk, Elaine Lam, Amir Mortazavi, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 7, 2021
Fluctuations in depression and anxiety predict dysregulated leptin among obese breast cancer survivors
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Iscience
|
June 13, 2024
Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition
Ronan C Bracken, Lindsay M Davison, Dennis P Buehler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Evaluation of <sup>18</sup>F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A
Mika Naganawa, Songye Li, Nabeel Nabulsi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 3, 2014
Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal
Kelly P Cosgrove, Reese McKay, Irina Esterlis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 10, 2017
Kinetic evaluation and test-retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
Sjoerd J Finnema, Nabeel B Nabulsi, Joël Mercier, et al.
Psycho-Oncology
|
June 25, 2022
Depression and anxiety in colorectal cancer patients: Ties to pain, fatigue, and inflammation
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
December 21, 2016
Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy
Lorena P Suarez-Kelly, Amanda R Campbell, Isaac V Rampersaud, et al.
Molecular Oncology
|
February 10, 2015
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz, Mohd W Nasser, Janani Ravi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 8, 2021
Assessment of test-retest reproducibility of [<sup>18</sup>F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
Songye Li, Mika Naganawa, Richard Pracitto, et al.
Page
of 92